Align Technology (XTER:AFW) Change In Payables And Accrued Expense: €-45 Mil (TTM As of Mar. 2026)

Align Technology XTER:AFW 89 Change In Payables And Accrued Expense is €-45 Mil as of Mar. 2026. GuruFocus rates XTER:AFW with a GF Score™ of 89/100 and a GF Value™ of €212.06 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Align Technology's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2026 was €8 Mil. It means Align Technology's Accounts Payable & Accrued Expense increased by €8 Mil from Dec. 2025 to Mar. 2026 .

Align Technology's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2025 was €-101 Mil. It means Align Technology's Accounts Payable & Accrued Expense declined by €101 Mil from Dec. 2024 to Dec. 2025 .

Align Technology Change In Payables And Accrued Expense Related Terms

Align Technology Change In Payables And Accrued Expense Historical Data

* Premium members only.

The historical data trend for Align Technology's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Align Technology Change In Payables And Accrued Expense Chart

Align Technology Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

168.80

-143.62

28.29

65.50

-101.28

Align Technology Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-51.79	17.39	-9.32	-61.25	8.12

89GF Score

Align Technology Inc XTER:AFW

Change In Payables And Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Align Technology Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-45 Mil.

Frequently Asked Questions Learn more about Change In Payables And Accrued Expense →

What does a Change In Payables And Accrued Expense of €-45 Mil mean?

Align Technology (XTER:AFW) has a Change In Payables And Accrued Expense of €-45 Mil as of Mar. 2026. Change In Payables And Accrued Expense is any increase or decrease between periods of the payables and accrued expense. View historical data on Align Technology and its competitors.

Is Align Technology's Change In Payables And Accrued Expense too high?

Align Technology's current Change In Payables And Accrued Expense is €-45 Mil. Overall, Align Technology has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Align Technology's Change In Payables And Accrued Expense compare to SOLV and COO?

Align Technology's Change In Payables And Accrued Expense of €-45 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Payables And Accrued Expense for a Medical Devices & Instruments company?

A good Change In Payables And Accrued Expense depends on the Medical Devices & Instruments industry context. However, Change In Payables And Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Payables And Accrued Expense mean?

A high Change In Payables And Accrued Expense can signal that a stock is expensive relative to its fundamentals. Change In Payables And Accrued Expense is any increase or decrease between periods of the payables and accrued expense. View historical data on Align Technology and its competitors. Align Technology's current Change In Payables And Accrued Expense is €-45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Align Technology stock overvalued right now?

Based on GuruFocus' analysis, Align Technology (XTER:AFW) is currently considered Significantly Undervalued. The stock's GF Value™ is €212.06, compared to a current price of €149.05 — trading 29.7% below its estimated fair value. The current Change In Payables And Accrued Expense is €-45 Mil. Align Technology's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Payables And Accrued Expense calculated?

Change In Payables And Accrued Expense is calculated from a company's financial statements. For Align Technology (XTER:AFW), the current Change In Payables And Accrued Expense is €-45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Align Technology (XTER:AFW) Overvalued in 2026?

Based on GuruFocus' analysis, Align Technology stock appears to be undervalued. The current stock price of €149.05 is trading 29.7% below its estimated GF Value™ of €212.06. GuruFocus considers Align Technology to be Significantly Undervalued.

Key valuation signals for XTER:AFW:

Change In Payables And Accrued Expense: €-45 Mil
GF Value™: €212.06 vs. price of €149.05 (29.7% below fair value)
GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the XTER:AFW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Align Technology Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies SOLV COO BAX ATR RGEN AVTR TFX STVN NVST MMSI ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST TSE:4543 XPAR:DIM

Other Exchanges ALGN:USA ALGN:Mexico 1ALGN:Italy 0HCK:UK AFW:Germany A1LG34:Brazil ALGN:Austria

Address 410 North Scottsdale Road, Suite 1300, Tempe, AZ, USA, 85288

Website https://www.aligntech.com

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

89GF Score

Get the complete analysis for XTER:AFW

Change In Payables And Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€149.05

Price

€212.06

GF Value

View XTER:AFW Analysis

See Change In Payables And Accrued Expense data for all stocks →